ACCPNephroPRN

The American College of Clinical Pharmacy's Nephrology PRN is a collegial network of pharmacists that practice in acute and chronic care of kidney disease

[NDT @NDTsocial]

International consensus on post-transplantation diabetes mellitus

🔓https://t.co/dsWfZ5Vmpv

[KDIGO @goKDIGO]

We are excited to share that the KDIGO Blood Pressure in CKD Guideline is now digitally available for FREE in Acumen Epic Connect via @AvoMD, allowing you to save time and standardize evidence-based care! Get started by reaching out to [email protected].

#Nephrology #CKD #BP #ClinicalDecisionSupport #EPIC #KDIGO #AvoMD

[ACCPNephroPRN @ACCPNephro]

👀 Check out the latest release of CE modules for management of #CKD! 👇

#NephTwitter #TwitteRx

[AKHOMM @kidneymedmgmt]

We are excited to share that we have added five new modules to our curriculum!

Register today at: https://t.co/V8xo4JnHWx

[ACCPNephroPRN @ACCPNephro]

Neph PRN Social Hour starting now! 👇

https://t.co/BSfMDvCZZv

[KDIGO @goKDIGO]

Check out the May issue of KDIGO Direct for the latest news and updates from KDIGO: https://t.co/Ie87BPlZYV.



In this issue: International Consensus Statement on Standardized Blood Pressure Measurement, the KDIGO Home Dialysis Controversies Conference Report, the 2023 ANCA Guideline for public review, upcoming webinars, new resources, and more. 


#BP #bloodpressure #ANCA #AAV #CKD #genetics #genomics #homedialysis #dialysis #glomerular

[ACCP Adult Med PRN @accpamedprn]

📣 Join us tomorrow for our monthly journal club by some awesome PGY-2 Pharmacotherapy and Internal Medicine Residents! Zoom link can be found in your email #AMEDPRN @HFHPharmRes @RxCutshall @candradhubbard @MUHPharmRes @dukerxresidency

[AKHOMM @kidneymedmgmt]

Our new curriculum is LIVE. 🎉 If you want to learn more about Slowing Kidney Disease Progression, enroll at the link in our bio.

#TwitteRX #pharmacists #AKHOMM #NephTwitter #kidneycare #PharmacyUMN #GetTheMedicationRight #nephrologist #nephrologynurse #nursepractitioner

[KDIGO @goKDIGO]

KDIGO is pleased to announce the publication of the Home Dialysis Controversies Conference Report in the May 2023 issue of @Kidney_Int. The conference was co-chaired by @PD_Perls and @wilkiemart.

Read the news release: https://t.co/Y1A0HMdfeH

Download the conference report: https://t.co/0Z8FNwpx5P

[ACCP Health Equity PRN @accphleqprn]

🗓 SAVE THE DATE! We are partnering with @ACCPNephro to co-host a webinar, Removing Race from the eGFR Calculation. Presented by @WendyStPeter002 and moderated by @JayCdoesID on April 19th via Zoom. Register here: https://t.co/FJlDLtjBOr
@RenaGosser @rx_phan

[Erin Barreto @erin_barreto]

The magic of evolving in #criticalcare is appreciating where your patient is on the curve and determining what that means, add add add, hold up, or put Humpty Dumpty back together.

Being mindful of the creatinine blind period is as important in deterioration as recovery!

[ACCPNephroPRN @ACCPNephro]

Includes a nice review of clinical trials too!

And of course, #pharmacists can play 🔑 roles in supporting #adherence (*cough*pseudoresistance*cough* 😉) and best medication use practices!

[NDT @NDTsocial]

🚨NEW Review:
Resistant hypertension in dialysis
📖https://t.co/O31k9U8TVz
📸Proposed work-up of dialysed patients with apparent treatment-resistant hypertension

[AKHOMM @kidneymedmgmt]

Meet the team that’s accelerating the implementation of comprehensive medication management services for those with kidney disease in the U.S.

#TwitteRX #pharmacists #AKHOMM #NephTwitter

[KDIGO @goKDIGO]

KDIGO is pleased to announce the formal launch of an update to its 2012 Acute Kidney Injury (#AKI) Guideline. Matthew James (Canada) and @MarliesOsterman (United Kingdom) will co-chair the guideline update.

Read the full News Release: https://t.co/LeOT7HK7xl

[Pharmacotherapy @PharmacoJournal]

Vancomycin 5–7.5 mg/kg q12h is recommended as the initial dosage regimens for ICU patients undergoing CRRT. https://t.co/K4bU7uj0SD @accpinfdprn

[Pharmacotherapy @PharmacoJournal]

These accurate models could assist clinicians in predicting tacrolimus efficacy in pediatric patients with nephrotic syndrome before utilization to avoid treatment failure or adverse effects. https://t.co/Li3Duhuvb9 @accppediprn @ACCPNephro

[Pharmacotherapy @PharmacoJournal]

Dose optimization utilizing TDM early in cefepime treatment may minimize adverse effects and improve patient safety. https://t.co/5NnEIBobrD @Veena_PharmD @accpinfdprn @ACCPNephro

[ACCPNephroPRN @ACCPNephro]

#TwitteRx -- what are YOU wanting to 👀 in future @ACCP #NephPRN CE sessions?

Tell us in a 1-minute, one question survey! 👇

https://t.co/8QjbHHbRT7

[ACCPNephroPRN @ACCPNephro]

@ASNKidney #KidneyWk starts this Thursday, 11/03/2022!

#TwitteRx... who's going??

[ACCPNephroPRN @ACCPNephro]

@accpambuprn @accpendoprn

[KDIGO @goKDIGO]

Check out the Top 10 Takeaways for Patients from the KDIGO 2022 Diabetes in CKD Guideline: https://t.co/UyuaRC0jaU

For more resources, visit the KDIGO Diabetes Guideline website: https://t.co/kTvlEWhx4Q

#diabetes #CKD #SGLT2 #SGLT2i #metformin #CGM #T2D #T1D #glucose #glycemic

[KDIGO @goKDIGO]

KDIGO is pleased to announce the publication of the 2022 Diabetes Management in CKD Guideline.

Read the Guideline:
https://t.co/A6LdZbr3qg

Read the Executive Summary:
https://t.co/vnt32SGix3

Read the News Release:
https://t.co/LMc8JRFyM2

#diabetes #CKD